Days
Hours
Minutes
Seconds

Important Dates:

April 15, 2026
Author Notification

📥 📝 JF Submission Deadline:

    April 1, 2026

📬 Notification of Acceptance:

    April 15, 2026

🎤 Main Conference:

    July 7–10, 2026

Call for Papers

📣 AIME 2026 – Journal First track - Call for Journal First Papers

For the first time in AIME’s history, AIME 2026 will welcome a new track for journal-first contributions into its scientific program. Authors of journal papers that were:

  • Recently accepted, i.e., in the last 18 months before the conference date, with possible exceptions for highly relevant submissions
  • Journal-first, i.e., not a journal extension of a prior conference publication (including previous AIME conference editions or other conferences)

Are invited to submit their work for presentation at AIME 2026.

Papers must focus on a novel methodological contribution in the field of AI in biomedicine/healthcare, or present results of a real-world evaluation study of AI tools in a healthcare setting. Regardless of the journal, submissions must demonstrate a clear AI contribution and a medical/healthcare application focus.

📆 Important Dates – AIME 2026

📥 Submission Deadline
April 15, 2026
🎤 Main Conference
April 1, 2026
📬 Notification of Acceptance
July 7-10,2026

All dates and times are Anywhere on Earth (AoT) 
Submission deadline: April 1st, 2026
Author notification: April 15th, 2026

📚 Relevant journals (examples only)

The following is a non-exhaustive list of example journals and journal categories relevant to journal-first submissions to AIME. Papers from other reputable peer-reviewed journals are welcome, provided they meet the criteria and are clearly in scope (see below).

Medical Informatics and Health AI journals:

  • Artificial Intelligence in Medicine (AIIM)
  • Journal of Biomedical Informatics (JBI)
  • npj Digital Medicine
  • Journal of the American Medical Informatics Association (JAMIA)

AI and Computer Science journals:

  • Artificial Intelligence Journal (AIJ)
  • Nature Machine Intelligence
  • Information Fusion

Patterns Engineering / Imaging / Biomedical Engineering journals:

  • Medical Image Analysis
  • IEEE Journal of Biomedical and Health Informatics

Medical journals:

  • JAMA (and related journals, e.g., JAMA Network Open)
  • NEJM AI
  • The Lancet (and related journals)

Computational Biology and Bioinformatics journals:

  • Briefings in Bioinformatics
  • PLOS Computational Biology
  • NAR Genomics and Bioinformatics
  • Computers in Biology and Medicine

🧩 Journal-first submissions criteria:

Journal-first submissions must adhere to the following criteria:

  • The paper was accepted to the journal no earlier than Oct 1st, 2024, and no later than March 31, 2026. Note: exceptions to this timeframe are possible for exceptionally relevant contributions; reasons for the exception should be briefly stated in the presentation proposal. Note that this date refers to the date of the official acceptance decision communicated by the journal.
  • The paper is not a journal extension of prior conference work (including previous AIME conference editions).
  • The paper is in the scope of AIME 2026.
  • The paper reports novel contributions not previously reported in prior work.
  • The paper has not been presented at, and is not under consideration for, journal-first tracks of any other conferences.

By submitting, the authors confirm that the paper meets the journal-first criteria above.

📨 How to submit

Authors of a paper that meets the above criteria are invited to submit a (maximum) two-page presentation proposal.  The proposal must include:

  1. The paper’s title and authors
  2. An abstract (can be the journal abstract or an adapted version)
  3. A “Why AIME?” relevance justification (2–5 sentences) explaining why the paper is a strong fit for AIME 2026 and which AIME themes/topics it addresses
  4. A pointer (URL) to the original journal paper on the journal’s website
    • If the paper is accepted but not yet accessible on the journal’s website, a link to a preprint may be provided; in this case, please include a copy of the formal acceptance letter with the submission.
  5. If the journal paper is related to, or builds on any previously published work (e.g., a tool demo, poster, workshop paper, etc.), the proposal must explicitly justify why the paper should be considered journal-first under the criteria above.

Submission format:  At the time of submission, the proposal must have no more than 2 pages total (including all text, figures, and references). Submissions format  must adhere to AIME 2026 formatting guidelines (Springer LNCS), as for other AIME 2026 submission types.

Proposals must be written in English, submitted in PDF format, and submitted electronically through EasyChair, under the Journal-First Track category. Submissions that do not comply with the above instructions will be desk-rejected without review.

🧠 Evaluation

Since the papers have already been reviewed and accepted by the journals, they will not be peer-reviewed again for technical or scientific content. Instead, the scientific committee will screen proposals based on:

  • Scope and fit with AIME 2026
  • Clarity of the proposal and relevance justification
  • Interest to the AIME community
  • Building a balanced program across AIME topics

 

Authors of selected journal-first submissions will be invited to present their contribution at AIME 2026.

🗣️ Presentation

At least one author of each presentation accepted for the journal-first program must register and attend the conference in person in Ottawa, Canada, to present the paper. Note that the journal-first manuscripts are published through the journals and will not be part of the Proceedings of the AIME 2026 conference. The journal-first papers will be listed in the conference program; AIME 2026 participants will have access to the paper abstracts and a pointer to the journal publication outside the conference proceedings.

🧑‍⚖️ Journal-First track co-chairs:

Enea Parimbelli, Biomedical Informatics (BMI) Lab “Mario Stefanelli”, University of Pavia, Italy; Chief Health AI Officer, IRCCS Mondino Foundation, Pavia, Italy;